Novation contracts Amersham for nuclear medicine products

TriMed Staff | | Health Imaging | Practice Management
Amersham Health has received a three-year contract from Novation for its nuclear medicine radiopharmaceutical and related products.

 The pact is effective Jan. 1, 2004 through Dec. 31, 2006.

 The Buckinghamshire, United Kingdom company will provide the group purchasing company with products, such as its Myoview kit for the preparation of Technetium Tc99m and Tetrofosmin injection for myocardial perfusion.

 Novation is the supply company of VHA Inc., based in Irving, Texas, and University HealthSystem Consortium (UHC), which operates from Oakbrook, Ill.

TriMed Staff

Related Content

Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
Bracco's latest move marks a step toward improving sustainability in radiology
New protocol addresses contrast allergies in patients with suspected stroke
Do large language models help or hinder workflows related to radiology reports?

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.